CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

CCCCC4 Therapeutics, Inc.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $3.33 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$409.67M
RECENT INSIDER TRADES
  • 2026-10-02 · Anderson Kenneth Carl (Director) · OTHER
  • 2026-10-02 · GROGAN DONNA ROY (Director) · OTHER
  • 2026-09-21 · Adams Kendra (Chief Financial Officer) · OTHER
  • 2026-07-13 · REYNO LEONARD (Chief Medical Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders157
Shares held128,010,511
Value$570.38M
Percent of shares outstanding104.05%
As of quarter end2026-06-30
RECENT NEWS
  • JPMorgan initiates C4 Therapeutics stock coverage at Overweight
  • C4 Therapeutics presents cemsidomide biomarker data from Phase 1 trial
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
C4 Therapeutics, Inc. (CCCC) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit